Despite this, we found that miR‐126 expression positively correlated with expression of its host gene EGFL7, and inversely correlated with its putative target p85β, in CLL patients both before and during ibrutinib treatment. Here, EGFL7 is linked to B-cell chronic lymphocytic leukemia.